
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
3/10/2026
0:00
30:21
In this episode of Conversations in Drug Development, host Harriet Edwards is joined by Kelsey Lennoch and Eamon McGowran to discuss the EU Biotech Act, a major regulatory proposal aimed at revitalizing Europe’s biotech sector. They explore the act’s goals to streamline clinical trial processes, harmonize regulations, and boost funding for late-stage biotech companies. The conversation highlights key changes for medicines and medical devices, the act’s potential impact on innovation and competitiveness, and the importance of ongoing engagement as the EU’s regulatory landscape evolves. For more information, visit www.boydconsultants.com.
More episodes from "Conversations in Drug Development"



Don't miss an episode of “Conversations in Drug Development” and subscribe to it in the GetPodcast app.








